MITO

Stealth BioTherapeutics Corp. ADS

Delisted

MITO was delisted on the 15th of November, 2022.

7 hedge funds and large institutions have $3.11M invested in Stealth BioTherapeutics Corp. ADS in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
KCM
1
Kingdon Capital Management
New York
$2.23M
Millennium Management
2
Millennium Management
New York
$434K -$195K -16,124 -31%
Bank of America
3
Bank of America
North Carolina
$410K +$108K +8,604 +36%
UBS Group
4
UBS Group
Switzerland
$26K +$25.2K +2,016 +3,102%
CCA
5
Catalyst Capital Advisors
New York
$7K
Deutsche Bank
6
Deutsche Bank
Germany
$2K +$2K +215 New
DIM
7
DC Investments Management
Virginia
-$646K -50,420 Closed